Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,295 public trials 1,284 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Not Yet Recruiting

Clinical Genetics Branch Eligibility Screening Survey

NCT07005297

Conditions: Abnormalities, Multiple, Anemia, Anemia, Aplastic, +44 more
Locations: National Cancer Institute Rockville, Maryland, United States

View Trial Details

Not Yet Recruiting

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

NCT07740941

Conditions: Melanoma, Melanoma (Skin Cancer), Melanoma Stage IV, +13 more
Locations: Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Not Yet Recruiting

Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma

NCT07747935

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

NCT07689812

Conditions: Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

NCT07743554

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

NCT07340619

Conditions: Melanoma, Metastatic (Stage IV) Melanoma, Neoplasm Metastasis, +14 more
Locations: Institut Bergonie Bordeaux, France

Centre Leon Berard Lyon, France

Institut Paoli Calmettes Marseille, France

Centre Antoine Lacassagne Nice, France

View Trial Details

Not Yet Recruiting

A Comparative Usability Study of Two Total Body Skin Imaging Systems

NCT07740642

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: University Hospital Basel Basel, Canton of Basel-City, Switzerland

View Trial Details

Not Yet Recruiting

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

NCT07574047

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: HFR Fribourg Fribourg, Canton of Fribourg, Switzerland

Ente Ospedaliero Cantonale (EOC) Bellinzona, Switzerland

Inselspital, Bern Bern, Switzerland

Hôpitaux Universitaires de Genève HUG Geneva, Switzerland

View Trial Details

Not Yet Recruiting

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

NCT07206849

Conditions: Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma

NCT07739017

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Royal Brisbane and Women's Hospital Herston, Queensland, Australia

Austin Health Heidelberg, Victoria, Australia

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions